People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gynesonics, Inc | — | Other Health Care | Series C | $299.1M | $1.0B | 2009 |
| Pulse Biosciences, Inc. | — | Biotechnology | Series C | $93.0M | $1.4B | 2017 |
| Auxogyn Inc | — | Other Health Care | Series B | $73.1M | $327.3M | 2015 |
Darrin Uecker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Darrin Uecker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Brown | 1 | 22 |
| Beth Seidenberg | 1 | 15 |
| Fred Cohen | 1 | 12 |
| JEFFREY SCHWARTZ | 1 | 9 |
| Simeon George | 1 | 8 |
| Greg Garfield | 1 | 8 |
| Joyce Erony | 1 | 8 |
| David Neustaedter | 1 | 7 |
| Jonathan MacQuitty | 1 | 7 |
| Mark Gudiksen | 1 | 5 |
| Amy Wang | 1 | 5 |
| Mark Weeks | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Tom Rodgers | 1 | 4 |
| Christopher M Owens | 1 | 3 |
| Gina Bartasi | 1 | 3 |
| Mike Carusi | 1 | 3 |
| Karen Talmadge | 1 | 3 |
| Doug Fisher | 1 | 3 |
| Christopher Marlett | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.